Negative Diffusion-Weighted Imaging After Intravenous Tissue-Type Plasminogen Activator is Rare and Unlikely to Indicate Averted Infarction
Stroke 44-1629-1634, Freeman, J.,et al, 2013
Stroke
Lancet 371:1612-1623, Donnan,G.A.,et al, 2008
Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 34:1056-1083, Adams,H.P.,et al, 2003
Intravenous tPA in Acute Ischemic Stroke Related to Internal Carotid Artery Dissection
Neurol 54:2159-2161, Derex,L.,et al, 2000
Diagnosis and Treatment of Ischemic Stroke
Am J Med 106:211-221, Alberts,M.J., 1999
Treating Ischemic Stroke as an Emergency
Arch Neurol 55:457-461, Adams,H.P., 1998
Ischemic Cerebral Infarction After rt-PA and Heparin Therapy for Acute Myocardial Infarction
Stroke 28:1107-1114, Sloan,M.A.,et al, 1997
Hemorrhagic Transformation in Acute Ischemic Stroke
Stroke 28:957-960, Larrue,V.,et al, 1997
Prethrombolysis Brain Imaging:Trends and Controversies
AJNR 18:1830-1834, Castillo,M., 1997
Pilot Randomized Trial of Tissue Plasminogen Activator in Acute Ischemic Stroke
Stroke 24:1000-1004, Haley,E.C.,et al, 1993
Fatal Ischaemic Brain Oedema after Early Thrombolysis with Tissue Plasminogen Activator in Acute Stroke
BMJ 297:1571-1574, Koudstaal,P.J.,et al, 1988
Current Medical & Surgical Therapy for Cerebrovascular Disease
NEJM 317:1505-1516, Grotta,J.C., 1987